Injectable, wire-free nerve-stimulation device shows early preclinical results
Researchers at NYU Abu Dhabi and Cleveland Clinic Abu Dhabi developed a seed-sized device that can be injected near a peripheral nerve and powered wirelessly outside the body. Laboratory and preclinical tests showed it could provide programmable stimulation and activate nerves in vivo. The study does not establish that the device relieves chronic pain or improves movement disorders in people.
The story
Scientists at NYU Abu Dhabi, working with Cleveland Clinic Abu Dhabi, reported an injectable, leadless bioelectronic interface for wireless peripheral neuromodulation. The seed-sized device is intended to be delivered through a standard needle and placed near a specific peripheral nerve, rather than surgically implanted with wires or an internal battery. An external source supplies power wirelessly, while the device delivers controlled electrical stimulation intended to alter nerve activity. According to the report, clinicians could use ultrasound and computed tomography to guide the device toward its target and check its position after placement. The stimulation is programmable, allowing the delivered signals to be adjusted. The researchers evaluated the technology in laboratory experiments and preclinical testing under conditions designed to resemble use outside an isolated laboratory. They also showed that it could activate nerves in vivo. The findings were published in Science Advances in a paper led by Mohamed Elsherif and senior author Khalil B. Ramadi. The authors frame the system as a possible additional option alongside medicines and surgically implanted stimulation devices for conditions involving unwanted or abnormal nerve activity. They specifically caution that effectiveness for relieving chronic pain or improving movement disorders in human patients has not yet been established.
Why it matters
Peripheral nerve stimulation can require an implanted device, a battery and connecting leads, all of which can make delivery more invasive. A device that is injected and powered externally could, if it proves safe and clinically effective, reduce the procedural burden associated with surgical implantation and allow stimulation settings to be changed without replacing a battery. Imaging compatibility is also a concrete operational feature: ultrasound and CT are identified as ways to guide placement and monitor the device. These potential advantages depend on future evidence that the implant stays positioned, functions reliably over time and produces benefits that outweigh risks for patients.
Evidence and context
The reported device belongs to peripheral neuromodulation, in which electrical signals are used to influence nerve activity. The source describes current care options as including medications and surgically implanted devices; this research is not presented as a replacement for either. Its technical distinction is the combination of needle delivery, leadless operation, external wireless power and programmable stimulation in one small implant. The study also addresses practical deployment questions beyond stimulation itself: the researchers report that familiar imaging methods can locate the device for placement and later monitoring. The article describes the work as a bridge between non-invasive therapies and conventional implants, but that is a research aim rather than demonstrated clinical performance.
Limits and unknowns
This is early-stage evidence, not a human treatment result. The work included laboratory experiments, preclinical testing and in-vivo nerve activation, but the source does not identify the living model, provide follow-up duration, or report human safety, pain scores, movement outcomes or comparisons with existing therapies. Important unresolved questions include how consistently the device can be positioned near different nerves, whether it remains stable over time, how external powering performs in clinical settings, and what adverse effects might emerge. The article explicitly states that benefit for chronic pain and movement disorders in people has not been established.
Follow the story
Share it, watch the explainer, or continue with the reporting trail.
Story timeline
Study reported
ScienceDaily published New York University’s report on the Science Advances paper describing the injectable peripheral-neuromodulation device.
Injectable, wire-free nerve-stimulation device shows early preclinical results
A short visual explainer for readers who want the story in a different rhythm.
Highlights
- Early preclinical nerve activation
- Powered from outside the body
- Imaging could guide placement
- A possible less invasive option
Transcript
A seed-sized, injectable nerve stimulator has activated peripheral nerves in early preclinical tests.
Researchers from NYU Abu Dhabi and Cleveland Clinic Abu Dhabi built a wirelessly powered implant.
Researchers report ultrasound and CT can guide placement and check the implant's position afterward.
If it proves safe and effective, patients could get nerve stimulation without implanted wires or batteries.
Human safety and lasting performance still need testing; pain and movement benefits remain unproven.